How to mmd

What is Moyamoya Disease (MMD)?

Moyamoya disease (MMD) is a chronic, progressive cerebrovascular disorder that affects the arteries at the base of the brain. It is characterized by the gradual narrowing or complete blockage of the internal carotid arteries, which are major blood vessels supplying the brain. As these arteries become occluded, the brain attempts to compensate by forming fragile, abnormal new blood vessels (collateral circulation) at the base of the brain. These new vessels often appear as a hazy, wispy network on angiograms, resembling a 'puff of smoke,' which is the literal translation of 'moyamoya' in Japanese.

Causes and Risk Factors

The exact cause of Moyamoya disease is largely unknown, although it is believed to have a genetic component. In some cases, MMD can be associated with certain genetic syndromes and medical conditions, including:

• Neurofibromatosis type 1 (NF1)
• Down syndrome
• Turner syndrome
• Thyroid problems
• Sickle cell disease

MMD is more prevalent in East Asian populations, particularly in Japan and Korea, suggesting a genetic predisposition. However, it can occur in individuals of any ethnicity.

Symptoms of Moyamoya Disease

The symptoms of MMD vary depending on the age of onset and the severity of the arterial narrowing and collateral vessel formation. Symptoms typically arise from reduced blood flow to the brain (ischemia) or bleeding from the fragile collateral vessels (hemorrhage).

In Children:

• Transient Ischemic Attacks (TIAs): Also known as mini-strokes, these are temporary episodes of stroke-like symptoms that usually resolve within minutes to hours. Common triggers include crying, hyperventilation, or exertion, which cause changes in blood flow. Symptoms can include weakness or numbness in the face, arm, or leg, difficulty speaking, or vision problems.
• Strokes: Permanent brain damage can occur if blood flow is severely restricted or if the collateral vessels rupture.
• Headaches: While less common in children than adults, headaches can occur.
• Seizures: These can be a symptom of reduced blood flow or irritation to brain tissue.

In Adults:

• Strokes: This is the most common presenting symptom in adults, often due to bleeding from the fragile collateral vessels.
• Intracerebral Hemorrhage: Bleeding within the brain tissue.
• Subarachnoid Hemorrhage: Bleeding into the space between the brain and the membranes that cover it.
• Headaches: Often described as severe and debilitating.
• Cognitive Changes: Difficulties with memory, concentration, and executive functions.
• Movement Disorders: Involuntary movements, such as chorea, can occur.

Diagnosis of Moyamoya Disease

Diagnosing MMD involves a combination of medical history, neurological examination, and imaging studies. Key diagnostic tools include:

• Magnetic Resonance Angiography (MRA): This non-invasive imaging technique uses MRI to visualize blood vessels and identify narrowing or blockages.
• Computed Tomography Angiography (CTA): Similar to MRA, CTA uses CT scans and contrast dye to create detailed images of the brain's blood vessels.
• Cerebral Angiography: This is considered the gold standard for diagnosing MMD. It involves inserting a catheter into an artery (usually in the groin) and guiding it to the brain, where contrast dye is injected to visualize the blood vessels in high detail. This procedure can definitively show the characteristic narrowing of the carotid arteries and the presence of moyamoya vessels.
• Transcranial Doppler Ultrasound: This can help assess blood flow velocity in the brain's arteries.

Treatment and Management

There is no cure for Moyamoya disease, but treatments aim to prevent strokes and manage symptoms. The primary goals are to improve blood flow to the brain and reduce the risk of bleeding.

Medications:

• Antiplatelet agents (e.g., aspirin): Used to prevent blood clots.
• Anticoagulants: May be used in specific situations to prevent clot formation.
• Calcium channel blockers: Sometimes prescribed to help relax blood vessels and improve blood flow, especially in individuals who experience symptoms triggered by cold or hyperventilation.

Surgical Procedures:

Surgery is often recommended for individuals with MMD, particularly those who have experienced TIAs or strokes, or who show significant arterial narrowing. The main surgical approaches aim to restore blood flow to the brain:

• Direct Revascularization: This involves surgically connecting a blood vessel from the scalp (superficial temporal artery) directly to an artery on the surface of the brain. This provides a direct route for blood to reach the brain.
• Indirect Revascularization: This technique involves placing blood vessels from the scalp or muscles onto the surface of the brain, allowing new blood vessels to grow into the brain over time (angiogenesis). This is often performed in multiple stages.
• Combination Procedures: Sometimes, both direct and indirect techniques are used.

The choice of surgical procedure depends on the patient's age, overall health, and the specific characteristics of their MMD.

Prognosis

The prognosis for individuals with Moyamoya disease varies widely. With appropriate medical and surgical management, many individuals can lead relatively normal lives and significantly reduce their risk of stroke. However, MMD is a progressive condition, and ongoing monitoring and management are crucial throughout a person's life. Regular follow-up appointments with a neurologist or neurosurgeon are essential to monitor disease progression and adjust treatment as needed.